PUBLISHER: The Insight Partners | PRODUCT CODE: 2042675
PUBLISHER: The Insight Partners | PRODUCT CODE: 2042675
The continuous ambulatory peritoneal dialysis market is projected to reach US$1.76 billion by 2034 from US$1.33 billion in 2025. The market is estimated to register a CAGR of 3.1% during 2026-2034. Major factors driving the market growth include the escalating prevalence of chronic kidney disease and end-stage renal disease, increasing aging population requiring convenient renal care, and advancements in dialysate formulations and catheter technologies. Further, integration of telehealth and remote monitoring technologies will likely boost the market during the forecast period. However, shortage of trained professionals and patient awareness are among the market deterrents.
The growing population size is amplifying the need for convenient renal care modalities such as CAPD. The World Health Organization (WHO) projects that the number of people aged 60 and older will rise from 1.1 billion in 2023 to 1.4 billion by 2030. The United Nations World Population Aging reports indicate that persons aged 65 and over will increase worldwide, with the proportion in developed countries rising from 20% to 28% by 2050. The number of people aged 80 or older is projected to triple between 2020 and 2050, reaching 426 million, driven by longer life expectancies and declining birth rates. Among Chinese women, CKD prevalence climbs from 7.4% in those aged 18-39 to 24.2% for those over 70. This demographic shift correlates with higher CKD rates, as the CDC notes that CKD affects 34% of adults aged 65 and older in the US, compared to 6% in those aged 18-44. Older adults often present with comorbidities such as hypertension and diabetes, accelerating progression to ESRD and necessitating dialysis that accommodates reduced mobility and frailty.
CAPD offers distinct advantages for this demographic by providing flexible, home-based therapy that minimizes travel to dialysis centers and supports independence. Elderly patients on CAPD can perform exchanges during daily routines, preserving quality of life and reducing caregiver burden compared to in-center hemodialysis schedules. Studies highlight that aging-related declines in vascular access suitability make peritoneal approaches preferable, as they avoid repeated needling and lower infection risks in frail individuals when supported by assisted PD programs. Global inclinations show rapid aging in low- and middle-income countries, where infrastructure for facility-based care is strained, elevating CAPD's appeal for convenient, cost-effective management. The GBD 2023 data reinforces this, linking population aging to an 18.9% crude increase in CKD prevalence since 1990. As life expectancy rises and more seniors reach ESRD stages, CAPD's portability and self-management features align with the growing preference for home-centric renal care, enabling better long-term adherence and outcomes in an elderly patient base.
The comparative company analysis evaluates and categorizes the continuous ambulatory peritoneal dialysis market based on product portfolio (product satisfaction, product features, and availability), recent market developments (merger & acquisition, new product launch & enhancement, investment & funding, award, agreement, collaboration, & partnership, recognition, and expansion), and geographic presence that aids better decision-making and understanding of the competitive landscape. The report profoundly explores the recent significant developments and innovations by the leading vendors in the global Continuous Ambulatory Peritoneal Dialysis Market. The key market players are Baxter International Inc, Fresenius Medical Care AG & Co KGaA, Terumo Corp, Medtronic Plc, JMS Co., Ltd., Polymedicure, Advin Health Care Pvt. Ltd., Utah Medical Products Inc, Mitra Industries Pvt. Ltd., and Newsol Technologies Inc.
In terms of product, the continuous ambulatory peritoneal dialysis market is bifurcated into peritoneal dialysis solution, peritoneal dialysis catheters, peritoneal dialysis transfer sets, and others. The peritoneal dialysis solution segment held a larger market share in 2025, owing to acceptance due to recurring usage in every dialysis cycle, increasing patient population, advancements in biocompatible solutions, and rising preference for home-based dialysis treatments globally.
The continuous ambulatory peritoneal dialysis market is categorized into in-center dialysis settings, home care settings. The in-center dialysis settings segment held a larger share of the market in 2025. Higher patient monitoring, availability of trained staff, better management of complications, established reimbursement frameworks, access to advanced APD equipment, and preference for supervised treatment in critical cases drive in-center segment dominance.
Companies operating in the continuous ambulatory peritoneal dialysis market adopt various organic and inorganic strategies. Organic strategies mainly include product launches and product approvals. Inorganic growth strategies witnessed in the market are acquisitions, collaborations, and partnerships. These growth strategies allow the market players to expand their businesses, enhance their geographic presence, and contribute to the overall market growth. Furthermore, acquisitions and partnerships helped strengthen their customer base and extend their product portfolios. A few significant developments by key continuous ambulatory peritoneal dialysis market players are listed below.
In June 2025, Fresenius Medical Care received FDA 510(k) clearance for an enhanced 5008X CAREsystem and began rollout at select Fresenius Kidney Care locations. A commercial release is planned for 2026 to expand high-volume hemodiafiltration and to integrate Clinical Data Exchange.
In February 2025, Baxter filed a correction for MiniCap EL peritoneal dialysis transfer sets due to elevated PCBA levels in peroxide-cured silicone tubing. Patients should continue therapy, with platinum-cured tubing prioritized for those under six months. Distribution guidance has been issued for healthcare providers and suppliers.